Hardie Robert D.
SEC CIK 1804350 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABOS | Acumen Pharmaceuticals, Inc. | 10% | 3.20M | $17.00M | — | 4 | 2021-07-06 | 2021-07-06 |
Most active insiders at ABOS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meisner Derek M | CLO, Corp Sec | — | $248.8K |
| 2 | OConnell Daniel Joseph | CEO, Dir | — | $163.2K |
| 3 | Porter Derrell | Dir | — | $75.2K |
| 4 | Zuga Matt | CFO, Chief Business Off | — | $49.6K |
| 5 | Barton Russell | COO | — | $30.0K |
| 6 | Siemers Eric | Chief Medical Off | — | $27.1K |
| 7 | Doherty James J. | Pres, CDO | — | $15.2K |
| 8 | Fountain Nathan B | Dir | — | $14.3K |
| 9 | Schacterle Amy | Chief Regulatory Off | — | $2,172 |
| 10 | Stoppel Laura | Dir | — | — |
Hardie Robert D. made no open-market trades at ABOS in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2021-07-08 | 2021-07-06 | ABOS | Acumen Pharmaceuticals, Inc. | Hardie Robert D. | 10% | C - Cnv Deriv | — | +3.20M | 3.20M | New | — |
| DI | 2021-07-08 | 2021-07-06 | ABOS | Acumen Pharmaceuticals, Inc. | Hardie Robert D. | 10% | P - Purchase | $16.00 | +750.0K | 3.95M | +23% | +$12.00M |
| DI | 2021-07-08 | 2021-07-06 | ABOS | Acumen Pharmaceuticals, Inc. | Hardie Robert D. | 10% | P - Purchase | $16.00 | +312.5K | 3.35M | +10% | +$5.00M |
| DMI | 2021-07-08 | 2021-07-06 | ABOS | Acumen Pharmaceuticals, Inc. | Hardie Robert D. | 10% | C - Cnv Deriv | — | +3.61M | 658.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations